My entire issue with this company is that they just might not be able to prove the actual filter works in a clinical study. This would obviously be HORRENDOUS for the stock price. It would fall to sub $2.00 becuase essentially the company would be worthless. Why has it taken this long is what I continue to ask myself. That is why I sold at $12+. I said something is wrong on this call and Dr. Chan (I know him personally) has a bad tone in his voice. He knew the market was going to pummel this and I heard it in his voice. The tone was dismal and I strongly believe there is something wrong at this point. And, when I say "point" I mean 6 years after I bought the stock and thought we would be where we are not 4 years ago.
I suspect the dosing data will be present at the German Sepsis Society's conference to be held September 9-11, 2015 in Weimar, Germany. The German Sepsis Society and the International Cytosorb registry is put on/supported by the doctors at the Jena University Hospital and are part of SepNet. In addition, this conference was where they released the results of their German sepsis study. A follow up for this study regarding the new dosage results makes sense here.
News 
Market Data 
Discover 
